Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

LR Zacharski - Cancer letters, 2002 - Elsevier
The purpose of this review is to demonstrate the potential for development of coagulation-
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …

Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

LR Zacharski - Cancer letters, 2002 - pubmed.ncbi.nlm.nih.gov
The purpose of this review is to demonstrate the potential for development of coagulation-
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …

Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy.

LR Zacharski - Cancer Letters, 2002 - europepmc.org
The purpose of this review is to demonstrate the potential for development of coagulation-
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …

[引用][C] Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

LR ZACHARSKI - Cancer letters, 2002 - pascal-francis.inist.fr
Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

LR Zacharski - Cancer Letters, 2002 - infona.pl
The purpose of this review is to demonstrate the potential for development of coagulation-
reactive drugs for experimental cancer treatment. Improved cancer outcome has been …

[引用][C] Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy

LR Zacharski - Cancer Letters, 2002 - Elsevier Limited